Back to search

Article

Noncoding regulatory mutations contribute to the aberrant gene expression in neuroblastoma.

2026-08-15

Abstract excerpt

Comprehensive analyses of whole-genome and exome sequencing data from high-risk neuroblastoma tumors have revealed relatively few recurrent, clinically actionable protein-coding driver mutations at initial diagnosis. This observation suggests that noncoding genetic variation, which can alter regulatory sequences like promoters, enhancers and insulators and influence gene expression, may play a critical role in neu...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
7a2b9182-9770-5ce1-b94e-0f0533a6027f
DOI
10.64898/2026.08.10.743941
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Noncoding regulatory mutations contribute to the aberrant gene expression in neuroblastoma.DOI 10.64898/2026.08.10.743941
Select a neighboring publication to make it the new centre.